// App-Quantinova.ai

BS18 : Loss of full-length MYLK3 causes dilated cardiomyopathy via a MYL2-independent mechanism.

Researchers

Presenter

  • Jack Williams

Principal Investigators

  • Michelle Stewart

  • Andrew Tinker

  • Pedro Cutillas

  • Lou Metherell

Medical Centers

  • MRC Harwell

  • Queen Mary University Of London, Centre for Endocrinology William Harvey Research Institute London, LND ECM BQ United Kingdom, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Dilated cardiomyopathy

Biomarkers

  • Myosin Heavy Chain 8

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final